272 related articles for article (PubMed ID: 28652578)
1. Rare germline variants in ATM are associated with chronic lymphocytic leukemia.
Tiao G; Improgo MR; Kasar S; Poh W; Kamburov A; Landau DA; Tausch E; Taylor-Weiner A; Cibulskis C; Bahl S; Fernandes SM; Hoang K; Rheinbay E; Kim HT; Bahlo J; Robrecht S; Fischer K; Hallek M; Gabriel S; Lander ES; Stilgenbauer S; Wu CJ; Kiezun A; Getz G; Brown JR
Leukemia; 2017 Oct; 31(10):2244-2247. PubMed ID: 28652578
[No Abstract] [Full Text] [Related]
2. ATM serine/threonine kinase germline mutations in chronic lymphocytic leukaemia come in different flavours.
Rio-Machin A
Br J Haematol; 2022 Nov; 199(3):307-309. PubMed ID: 36111522
[No Abstract] [Full Text] [Related]
3. ATM mutations are rare in familial chronic lymphocytic leukemia.
Yuille MR; Condie A; Hudson CD; Bradshaw PS; Stone EM; Matutes E; Catovsky D; Houlston RS
Blood; 2002 Jul; 100(2):603-9. PubMed ID: 12091354
[TBL] [Abstract][Full Text] [Related]
4. Rare germline ATM variants of uncertain significance in chronic lymphocytic leukaemia and other cancers.
Petrackova A; Savara J; Turcsanyi P; Gajdos P; Papajik T; Kriegova E
Br J Haematol; 2022 Nov; 199(3):371-381. PubMed ID: 36029002
[TBL] [Abstract][Full Text] [Related]
5. ATM germline variants in a young adult with chronic lymphocytic leukemia: 8 years of genomic evolution.
Royo R; Magnano L; Delgado J; Ruiz-Gil S; Gelpí JL; Heyn H; Taylor MA; Stankovic T; Puente XS; Nadeu F; Campo E
Blood Cancer J; 2022 Jun; 12(6):90. PubMed ID: 35672297
[No Abstract] [Full Text] [Related]
6. ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2).
Jiang Y; Chen HC; Su X; Thompson PA; Liu X; Do KA; Wierda W; Keating MJ; Plunkett W
Blood Cancer J; 2016 Sep; 6(9):e465. PubMed ID: 27588518
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of deleterious ATM germline mutations in gastric cancer patients.
Huang DS; Tao HQ; He XJ; Long M; Yu S; Xia YJ; Wei Z; Xiong Z; Jones S; He Y; Yan H; Wang X
Oncotarget; 2015 Dec; 6(38):40953-8. PubMed ID: 26506520
[TBL] [Abstract][Full Text] [Related]
8. ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres.
Navrkalova V; Young E; Baliakas P; Radova L; Sutton LA; Plevova K; Mansouri L; Ljungström V; Ntoufa S; Davis Z; Juliusson G; Smedby KE; Belessi C; Panagiotidis P; Touloumenidou T; Davi F; Langerak AW; Ghia P; Strefford JC; Oscier D; Mayer J; Stamatopoulos K; Pospisilova S; Rosenquist R; Trbusek M
Haematologica; 2016 Sep; 101(9):e369-73. PubMed ID: 27479817
[No Abstract] [Full Text] [Related]
9. Targeting the Ataxia Telangiectasia Mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants.
Agathanggelou A; Weston VJ; Perry T; Davies NJ; Skowronska A; Payne DT; Fossey JS; Oldreive CE; Wei W; Pratt G; Parry H; Oscier D; Coles SJ; Hole PS; Darley RL; McMahon M; Hayes JD; Moss P; Stewart GS; Taylor AM; Stankovic T
Haematologica; 2015 Aug; 100(8):1076-85. PubMed ID: 25840602
[TBL] [Abstract][Full Text] [Related]
10. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
Renault AL; Mebirouk N; Fuhrmann L; Bataillon G; Cavaciuti E; Le Gal D; Girard E; Popova T; La Rosa P; Beauvallet J; Eon-Marchais S; Dondon MG; d'Enghien CD; Laugé A; Chemlali W; Raynal V; Labbé M; Bièche I; Baulande S; Bay JO; Berthet P; Caron O; Buecher B; Faivre L; Fresnay M; Gauthier-Villars M; Gesta P; Janin N; Lejeune S; Maugard C; Moutton S; Venat-Bouvet L; Zattara H; Fricker JP; Gladieff L; Coupier I; ; ; ; Chenevix-Trench G; Hall J; Vincent-Salomon A; Stoppa-Lyonnet D; Andrieu N; Lesueur F
Breast Cancer Res; 2018 Apr; 20(1):28. PubMed ID: 29665859
[TBL] [Abstract][Full Text] [Related]
11. Biallelic ATM alterations detected at diagnosis identify a subset of treatment-naïve chronic lymphocytic leukemia patients with reduced overall survival similar to patients with p53 deletion.
Lozano-Santos C; García-Vela JA; Pérez-Sanz N; Nova-Gurumeta S; Fernandez-Cuevas B; Gomez-Lozano N; Sánchez-Beato M; Sanchez-Godoy P; Bueno JL; Garcia-Marco JA
Leuk Lymphoma; 2017 Apr; 58(4):859-865. PubMed ID: 27499002
[TBL] [Abstract][Full Text] [Related]
12. ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin.
Navrkalova V; Sebejova L; Zemanova J; Kminkova J; Kubesova B; Malcikova J; Mraz M; Smardova J; Pavlova S; Doubek M; Brychtova Y; Potesil D; Nemethova V; Mayer J; Pospisilova S; Trbusek M
Haematologica; 2013 Jul; 98(7):1124-31. PubMed ID: 23585524
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress as a therapeutic perspective for ATM-deficient chronic lymphocytic leukemia patients.
Navrkalova V; Kafkova LR; Divoky V; Pospisilova S
Haematologica; 2015 Aug; 100(8):994-6. PubMed ID: 26314081
[No Abstract] [Full Text] [Related]
14. Feasibility of targeted next-generation sequencing of the TP53 and ATM genes in chronic lymphocytic leukemia.
Mansouri L; Sutton LA; Ljungström V; Sörqvist EF; Gunnarsson R; Smedby KE; Juliusson G; Stamatopoulos K; Nilsson M; Rosenquist R
Leukemia; 2014 Mar; 28(3):694-6. PubMed ID: 24172824
[No Abstract] [Full Text] [Related]
15. Familial chronic lymphocytic leukemia in two siblings with ATM/13q14 deletion and a similar pattern of clonal evolution.
Kostopoulos IV; Tsakiridou AA; Pavlidis D; Megalakaki A; Papadhimitriou SI
Blood Cancer J; 2015 Jul; 5(7):e322. PubMed ID: 26140430
[No Abstract] [Full Text] [Related]
16. Ataxia telangiectasia mutated germline pathogenic variant in adrenocortical carcinoma.
Torres MB; Diggs LP; Wei JS; Khan J; Miettinen M; Fasaye GA; Gillespie A; Widemann BC; Kaplan RN; Davis JL; Hernandez JM; Rivero JD
Cancer Genet; 2021 Aug; 256-257():21-25. PubMed ID: 33836455
[TBL] [Abstract][Full Text] [Related]
17. ATM mutations and protein expression are not associated with familial B-CLL cases.
Ishibe N; Goldin LR; Caporaso NE; Sgambati MT; Dean M; Albitar M; Manshouri T; Gerrard B; Marti GE
Leuk Res; 2003 Oct; 27(10):973-5. PubMed ID: 12860021
[No Abstract] [Full Text] [Related]
18. Missense mutations at ATM gene and cancer risk.
Vorechovsky I; Luo L; Ortmann E; Steinmann D; Dörk T
Lancet; 1999 Apr; 353(9160):1276. PubMed ID: 10217116
[No Abstract] [Full Text] [Related]
19. Germline mutations in Dok1 do not predispose to chronic lymphocytic leukemia.
Sellick GS; Coleman RJ; Talaban RV; Fleischmann C; Rudd MF; Allinson R; Catovsky D; Houlston RS
Leuk Res; 2005 Jan; 29(1):59-61. PubMed ID: 15541476
[TBL] [Abstract][Full Text] [Related]
20. NOD/SCID IL2Rγ-null mouse xenograft model of human p53-mutated chronic lymphocytic leukemia and ATM-mutated mantle cell lymphoma using permanent cell lines.
Verner J; Trbusek M; Chovancova J; Jaskova Z; Moulis M; Folber F; Halouzka R; Mayer J; Pospisilova S; Doubek M
Leuk Lymphoma; 2015; 56(11):3198-206. PubMed ID: 25827173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
